TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean ad libitum intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mental Health Treatment Engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Clinician Administered PTSD Scales (CAPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Neck Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: prosthetic migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Muscular lipid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscular collagen content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance Use Disorder (SUD) diagnosis based on DSM 5 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of myocardial segments classified with attenuation artifact
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HPV Vaccine Completion Rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: P-Glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Use of the Study Medication Every Day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of the Study Medication at the Same Time of Day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of the Study Medication Without an Extended Break or Any Break Between Packs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average number of visits omitted
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline Timed Up and Go (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative unplanned reoperation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Unplanned readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intracranial pressure variation or increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline Knee Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic alteration frequencies of TMPRSS2-ERG gene fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Corneal epithelial healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of clinically cured patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspartate Aminotransferase (AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alanine Aminotransferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life- Alzheimer Dementia (QOL-AD) total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence and frequency of hypoglycemia and hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Suicide Jumps
Endpoint domain: Mortality/survival
Primary endpoint: Legionella DNA load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Baseline-to-peak Physician Withdrawal Checklist change score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Digit Symbol-Coding Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Systolic ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of reticular pseudodrusen affected retinal area to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of urinary oxalate excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Procedure and Device Safety
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator's overall assessment of efficacy of FGTW on hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal half life for Fibrinogen antigen and activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Cumulative Acute Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Hair nicotine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Anemia during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pre-term birth
Endpoint domain: Mortality/survival
Primary endpoint: Histologic Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction time difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with metabolic syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cervical Dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: True Positive Rate for Detection of Tumor Location in Lymph Nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: True Positive Rate for Detection of Tumor Location in Visceral Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: True Positive Rate for Detection of Tumor Location in Bone Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: True Positive Rate for Detection of Tumor Location in Prostate Bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of patients maintaining average Hb concentration within target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Beta cell capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness of chronic kidney disease in T2D
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Values regarding chronic kidney disease in T2D
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Preferences regarding chronic kidney disease in T2D
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Variation of bone cortical porosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Stage change (upward) as defined by the S-weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Detectable Virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Intake of an unfamiliar vegetable
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise capacity (6 min walk)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Surgical Resident's Autonomy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in Surgical Resident's Operative Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Surgical Resident's Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sodium Channel (NaCh) expression in nerves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: analgesia consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of incident HAI and/or colonization with MRSA or VRE
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Discontinue Study Treatment Due to an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: VAS-difference concerning the emotional valence of dreams
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tissue piercing
Endpoint domain: Adverse events/effects
Primary endpoint: Tissue tearing
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of pediatric asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Fluorescein Corneal Staining (FCS) Score From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lissamine Green Conjunctival Staining (LGCS) Score From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P53 levels in gingival biopsy samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in number of participants reporting sport sessions per week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of intraoperative embolic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Grade or size of embolic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change from baseline immunological factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cardiorespiratory and muscle fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatigue and quality of life
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Overall Satisfaction and Desire to Continue Wearing the Study Lenses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of children with IFX trough level in the range of 5 to 10 µg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chromosomal numerical aberrations during interphase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chromosomal differences after G banding technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: presence of SCE during metaphase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfactory Relief of Non-ulcer Dyspepsia Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weekly mean pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post treatment plaque score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: appropriateness of vancomycin use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hospitalization rate for HF worsening
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: All cause deaths
Endpoint domain: Mortality/survival
Primary endpoint: Number of hours receiving steroid dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular Pressure less than or equal to 21 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of agreement between reference tube size and final BEST-FIT ETT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Average Numeric Pain Intensity Scale (NPIS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost of PIPAC
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Standard uptake values (SUV) for 18Fluoro-deoxyglucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual Memory (Paired Associates Learning)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Executive Function (Spatial Working Memory)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Attention and Concentration (Reaction Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Specificity at Fixed 95-99% Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radial Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circumferential Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Soft tissue esthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of successful sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of hospital admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Frequency of infusion related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Retention at the end of the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participant rated satisfaction with the treatment protocol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant rated satisfaction with the treatment at large
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients with negative CD toxin in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of Women who received Intensity Modulated Radiation Therapy (IMRT) after Breast Conserving Surgery
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Women who received Tumor Biomarker Blood Testing for Surveillance
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Women who received Follow-Up Mammograms More Frequently than Annually for Patients Treated with Breast Conserving Surgery & Radiotherapy
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Change in intima-media thickness of the common carotid artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: At-risk drinking at 6 month followup
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: At-risk drinking at 12 month followup
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Long-term safety of the valve
Endpoint domain: Adverse events/effects
Primary endpoint: Durability of the valve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of new primary nonmelanoma skin cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: In stent late loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of Readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Loss of residual renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Technique (peritoneal dialysis) failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cmax of losartan and hydrochlorothiazide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of losartan and hydrochlorothiazide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of euploid embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HD-SCA liquid biopsy biosignatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HD-SCA solid tumor biosignatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Receiving Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent of Participants Who Were Histologic Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in The Dysphagia Symptom Questionnaire (DSQ) Score at The Final Treatment Period Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Resolution of sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Change in Resting Energy Expenditure (Kcal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in T Cells Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Safety profile of JTT-302
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Panic or anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: knee muscle strength recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tip-Apex distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular End-Systolic Volume Index (LVESVI) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline on PRL level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Binding of 18F-TARP252 in brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Who Withdrew From Treatment Due to TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Average concentration (Cav) of intracellular TFV-DP and FTC-TP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the time-concentration curve 0-24 hours (AUC0-24h) of intracellular TFV-DP and FTC-TP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcomes related to laparoscopic sleeve gastrectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Atrial fibrillation diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Punctum Plug retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment-related Grade 3 or 4 Local and Systemic Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of T-regulatory Cells (Tregs) and CD4+ and CD8+ Effector T Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the Number and Function of Peripheral Mesothelin-specific CD8+ T Cells and CD4+, FoxP3+, and GITR+ Tregs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement of symptom (Resolving anastomosis site stricture)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Activities of Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment of Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Assessment of Sleep Habits
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Periodontal Pockets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Missing teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of BTT1023
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polarization of lymphocyte responses towards a Th2 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Hemoglobin Measurements Within 10 to 11 g/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 8-OHdG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SN detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long term aseptic loosening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Performance error of predicted blood propofol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of successful primary weanings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Psychosocial Well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Completeness of Cytoreduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Perioperative and Postoperative Morbidity and Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Pharmacokinetics of ER pellet formulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Adverse Reaction (AE) and Severe Adverse Reaction (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Right ventricular diastolic area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular diastolic area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Eccentricity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time of re-epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Feasibility of transvaginal cholecystectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes